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Bacterial infections to anaerobic site are often hard to be treated because the activity
of most of antimicrobials decreases under anaerobic conditions. However, fosfomycin
rather provides a greater activity under anaerobic conditions than aerobic conditions.
Previously, we found that expression of glpT and uhpT, fosfomycin symporters in
enterohaemorrhagic Escherichia coli (EHEC) was upregulated by FNR, a global regulator
during the anaerobiosis of the bacterium, which led to increased uptake and susceptibility
to this drug. In this study, we showed that expression of glpT and uhpT is induced
by CRP-cAMP, the regulator complex under both aerobic and anaerobic conditions.
The activity of CRP-cAMP in EHEC was elevated under anaerobic conditions because
levels of both CRP and cAMP were higher in the cells when grown anaerobically than
those when grown aerobically. Results of expression study using mutants indicated that
CRP-cAMP is indispensable for expression of glpT but not uhpT—whereas that of uhpT
requires UhpA that is the response regulator composing of two-component system with
the sensor kinase, UhpB. The CRP-cAMP protein bound to a region that overlaps RNA
polymerase binding site for glpT and region upstream of UhpA binding site for uhpT.
FNR bound to a region further upstream of CRP-cAMP binding site on region upstream
of the glpT gene. These combined results suggested that increased antibacterial activity
of fosfomycin to EHEC under anaerobic conditions is due to activation of FNR and
increment of CRP-cAMP activity. Then, FNR enhances the expression of glpT activated
by CRP-cAMP while CRP-cAMP and FNR cooperatively aids the action of UhpA to
express uhpT to maximum level.
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INTRODUCTION
Fosfomycin is used for treatment of infectious diseases caused
by bacteria including E. coli, Pseudomonas aeruginosa and
Staphylococcus aureus. The antibiotic is effective against
multidrug-resistant (MDR) pathogens such as extended-
spectrum β-lactamase (ESBL) producers and quinolone resistant
strains because there is no cross resistance issue to other
commonly used antibiotics (Michalopoulos et al., 2011; Dinh
et al., 2012). In addition to this benefit, fosfomycin provides a
higher antimicrobial activity under anaerobic conditions than
aerobic conditions whereas many other antibiotics such as
fluoroquinolones and aminoglycosides are less effective under
anaerobic conditions (Inouye et al., 1989; Bryant et al., 1992;
Morrissey and Smith, 1994; Grif et al., 2001; Kohanski et al.,
2010). Bacteria often encounter non-oxygenic or micro-oxygenic
situations during infections. For E. coli, available oxygen is
depleted when they are in an enteric site and growing together
with other members in a microbial complex as biofilm.
Fosfomycin is transported to the cells via GlpT and
UhpT, glycerol-3-phosphate and glucose-6-phosphate
symporters, respectively, then antagonizes the binding of
phosphoenolpyruvate (PEP) to MurA that transfers PEP to
the 3′-hydroxyl group of UDP-N-acetylglucosamine in the
initial step for bacterial cell wall biosynthesis (Kadner and
Winkler, 1973; Argast et al., 1978; Bush, 2012). E. coli strains
that are resistant to fosfomycin have been isolated in clinical
settings, and these strains have mutations in uhpA and cyaA
genes. These genes encode the response regulator composing of
two-component system with the cognate sensor kinase, UhpB
activated by glucose-6-phosphate and adenylate cyclase that
synthesizes cyclic AMP (cAMP), respectively (Nilsson et al.,
2003; Takahata et al., 2010). Some laboratory studies in E. coli
showed that expression of the glpT gene is activated by the
complex of cAMP and its receptor termed cAMP receptor
protein (CRP), while that of the uhpT gene is activated by
both the CRP and cAMP complex (designated CRP-cAMP)
and UhpA (Schumacher and Bussmann, 1978; Merkel et al.,
1995). Hence, susceptibility to fosfomycin can be affected
by expression of the genes encoding GlpT and UhpT. The
effect of these regulatory elements on expression of glpT and
uhpT has been investigated in E. coli grown under aerobic
conditions because facultative anaerobe is often grown under
aerobic conditions in laboratory studies (Schumacher and
Bussmann, 1978; Merkel et al., 1995). For E. coli species
including EHEC, available oxygen is depleted at enteric sites
where they reside or cause infection. Therefore, studying on
regulation of glpT and uhpT genes in E. coli grown under
anaerobic conditions aids us to more precisely understand
efficacy of fosfomycin acting on this bacterium at the infection
sites.
We have been interested in studying on how antimicrobial
activity of fosfomycin is enhanced under anaerobic conditions.
Previously, we found that expression of glpT and uhpT
genes in EHEC are activated by FNR (Fumarate Nitrate
Reduction) in anaerobic culture, which led to increased
susceptibility to fosfomycin (Kurabayashi et al., 2015a). FNR
is a transcriptional regulator, and the protein is activated only
during the anaerobiosis (Green et al., 1996). Thus, increased
susceptibility of fosfomycin under anaerobic conditions is due
to elevated productions of GlpT and UhpT transporters via
activation of FNR.
In this study, we aim to get further insights into how
expression of glpT and uhpT is activated in anaerobically-grown
EHEC and how fosfomycin susceptibility is elevated. In addition
to FNR that we worked on in our previous study, we investigated
roles of CRP, cAMP and UhpA on susceptibility of EHEC to
fosfomycin and induction of glpT and uhpT in anaerobic culture.
Then, relationship among these regulatory elements was also
studied.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
The bacterial strains and plasmids used in this study are listed in
Table 1. All bacteria were grown in LB (Luria-Bertani) medium
(Nacalai tesque, Kyoto, Japan). For aerobic culture, EHEC strains
were grown in loosely capped glass tube with shaking at 160 rpm.
For anaerobic culture, we grew EHEC in a sealed container with
carbon dioxide gas generators, AnaeroPack-Anaero (Mitsubishi
Gas Chemical Co., Inc., Tokyo, Japan) for MIC assays. When
we need to monitor the cell growth by measuring absorbance
at 600 nm for RNA extraction and cyclic AMP assays, we
used Anaerobic Hungate culture tubes equipped with a rubber
stopper and a screw cap (Chemglass Life Sciences, Vineland, NJ).
For marker selection and maintenance of plasmids, antibiotics
were added to growth media at the following concentrations;
150 µg/ml ampicillin, 25 µg/ml kanamycin and 30 µg/ml
chloramphenicol.
Antibiotics and Reagents
We obtained antibiotics and reagents used in this study except
ampicillin, kanamycin, chloramphenicol and isopropyl β-D-
1-thiogalactopyranoside (IPTG) from Wako Pure Chemical
Industries, Ltd. (Osaka, Japan). Ampicillin, kanamycin,
chloramphenicol and IPTG were purchased from Nacalai tesque
(Kyoto, Japan).
Cloning and Mutant Constructions
In-frame deletions of crp, cyaA, and uhpA were constructed
by sequence overlap extension PCR according to a strategy
described previously (Link et al., 1997), with primer pairs,
delta1/delta2 and delta3/delta4 primers for each gene
as described in Table 2. The upstream flanking DNA
included 450 bp and the first three amino acid codons.
The downstream flanking DNA included the last two
amino acid codons, the stop codon, and 450 bp of DNA.
These deletion constructs were ligated into BamHI and
SalI-digested temperature sensitive vector pKO3 (Link
et al., 1997) and introduced into HH-H7-008, the parent
strain (Hirakawa et al., 2009). We selected sucrose-
resistant/chloramphenicol-sensitive colonies at 30◦C and
confirmed the resulting mutant strains using PCR analysis and
DNA sequencing.
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TABLE 1 | Strains and plasmids used in this study.
Strain or plasmid Relevant genotype/phenotype References
STRAINS
HH-H7-008 Parent strain (tnaA/lacZI deletion from EHEC O157:H7 (RIMD 0509952)) Hirakawa et al., 2009
HH-H7-095 glpT mutant from HH-H7-008 Kurabayashi et al., 2015b
HH-H7-097 uhpT mutant from HH-H7-008 Kurabayashi et al., 2015a
HH-H7-103 glpT/uhpT double mutant from HH-H7-008 Kurabayashi et al., 2015a
HH-H7-150 fnr mutant from HH-H7-008 Kurabayashi et al., 2015a
HH-H7-153 cyaA mutant from HH-H7-008 This work
HH-H7-174 uhpA mutant from HH-H7-008 This work
HH-H7-175 crp mutant from HH-H7-008 This work
RosettaTM (DE3) T7-expression strain, CmR Novagen/EMD Bioscience
PLASMIDS
pKO3 Temperature sensitive vector for gene targetting, sacB, CmR Link et al., 1997
pQE80L Vector for expression of His-tagged protein; ApR Qiagen
pQE80crp N-terminal His6-Crp overexpression plasmid; Ap
R This work
pTrc99-6HisD154Afnr N-terminal His6-D154AFNR overexpression plasmid; Km
R Kurabayashi et al., 2015a
pNN387 Single copy plasmid with promoterless lacZ; CmR Elledge and Davis, 1989
pNNglpT-P glpT promoter reporter; CmR Kurabayashi et al., 2015a
pNNuhpT-P uhpT promoter reporter; CmR Kurabayashi et al., 2015a
pTrc99A Vector for IPTG-inducible expression; ApR Kurabayashi et al., 2015b
pTrc99Afnr fnr expression plasmid; ApR This work
pTrc99AcyaA cyaA expression plasmid; ApR This work
pTrc99Acrp crp expression plasmid; ApR This work
pTrc99AuhpA uhpA expression plasmid; ApR This work
ApR, Ampicillin resistance; CmR, Chloramphenicol resistance; KmR, Kanamycin resistance.
To construct His6-CRP expression plasmid pQE80crp,
the crp gene was amplified with the primer pair shown
in Table 2. The product was digested with BamHI
and HindIII and ligated into similarly digested pQE80
plasmid.
To construct pTrc99Afnr, pTrc99AcyaA, pTrc99Acrp, or
pTrc99AuhpA for complementation tests, we amplified the fnr,
cyaA, crp or uhpA gene, and digested with NcoI and BamHI
for pTrc99Afnr, pTrc99Acrp, and pTrc99AuhpA or EcoRI and
BamHI for pTrc99AcyaA, then ligated into similarly digested
pTrc99A plasmid. All constructs were confirmed by DNA
sequencing.
Drug Susceptibility Assays
To test susceptibility of EHEC to fosfomycin, MIC assays were
performed by a serial agar dilution method with the standard
method of the Clinical and Laboratory Standards Institute (CLSI)
(Clinical Laboratory Standards Institute, 2011). To conduct
MIC assays under anaerobic conditions, we grew EHEC strains
without shaking in a sealed container with AnaeroPack-Anaero
for 20 h. After taking the cultures out the anaerobic container, five
thousand cells were immediately inoculated on Mueller-Hinton
agar (EIKEN Chemical Co., Ltd., Tochigi, Japan) containing
fosfomycin, and the agar plates were incubated in the sealed
container with fresh AnaeroPack-Anaero gas generator pack at
37◦C. The MICs were determined as the lowest concentration at
which growth was inhibited.
Promoter Assays
EHEC strains carrying pNN-glpT-P or pNN-uhpT-P, the LacZ
reporter plasmid, were aerobically or anaerobically grown
at 37◦C in LB medium. To measure lacZ expression from
pNN-uhpT-P, we added 25 µg/mL of glucose-6-phosphate
into the medium because the promoter activity of uhpT
gene was too low to be detected when glucose-6-phosphate
is absent. β-Galactosidase activities from lacZ expression
in cell lysates were determined as Miller’s method (Miller,
1992).
RNA Extraction and Quantitative
Real-Time PCR Analyses
Bacteria were grown to mid-logarithmic growth phase (OD600
∼0.4) in LB medium. Total RNA extraction and cDNA synthesis
were performed using SV Total-RNA Isolation System and
GoScript
TM
Reverse Transcription System as described by the
manufacturer (Promega Corp., Madison, WI). Real-time PCR
included 2.5 ng cDNA and 200 nMprimers in SYBR SelectMaster
Mix (Applied Biosystems, Foster City, CA) and were run on an
ABI Prism 7900HT Fast Real Time PCR System. Constitutively
expressed rrsA and rpoD genes that respectively encode 16S
ribosomal RNA and RNA polymerase sigma 70 factor were used
as an internal control (Kurabayashi et al., 2014). Primers are
listed in Table 2. Amplification plot and melting curve data are
available upon request.
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TABLE 2 | Primers used in this study.
Primer DNA sequence (5′–3′) Use
cyaA-delta1 gcgagatctagtgtgcctgccagagtgc cyaA mutant construction
cyaA-delta2 ccggcacgttcatcacgaaaagaggtacaagacgtatcgc cyaA mutant construction
cyaA-delta3 aggcgatacgtcttgtacctcttttcgtgatgaacgtgcc cyaA mutant construction
cyaA-delta4 gcggtcgactcatgccgtaacgcagccg cyaA mutant construction
uhpA-delta1 gcgggatccaattaccatcagcatgtcg uhpA mutant construction
uhpA-delta2 aacaacgtcttcatcaccagccggtgatcatgattgggtcc uhpA mutant construction
uhpA-delta3 ccaggacccaatcatgatcaccggctggtgatgaagacgttg uhpA mutant construction
uhpA-delta4 gcggtcgactaacagcagcgcattccac uhpA mutant construction
crp-delta1 gcgggatccacccgccgccatcaacacc crp mutant construction
crp-delta2 cactccgacgggattaacgagtaagcaccatgcgcggttatc crp mutant construction
crp-delta3 aggataaccgcgcatggtgcttactcgttaatcccgtcggag crp mutant construction
crp-delta4 gcggtcgacccagaccggcatgtatccc crp mutant construction
pQE-crp-F gcgggatccgtgcttggcaaaccgcaaac pQE80crp construction
pQE-crp-R gcgaagcttttaacgagtgccgtaaacgac pQE80crp construction
rrsA-qPCR-F cggtggagcatgtggtttaa Quantitative real-time PCR
rrsA-qPCR-R gaaaacttccgtggatgtcaaga Quantitative real-time PCR
rpoD-qPCR-F caagccgtggtcggaaaa Quantitative real-time PCR
rpoD-qPCR-R gggcgcgatgcacttct Quantitative real-time PCR
glpT-qPCR-F tgcccgcaggtttgattc Quantitative real-time PCR
glpT-qPCR-R ccatggcacaaagcccata Quantitative real-time PCR
uhpT-qPCR-F aagccgaccctggacctt Quantitative real-time PCR
uhpT-qPCR-R acggtttgaaccacattttgc Quantitative real-time PCR
cyaA-qPCR-F tgcctaagttgcaggagatggt Quantitative real-time PCR
cyaA-qPCR-R ggtaagcgcaacgggaaa Quantitative real-time PCR
crp-qPCR-F ccgtcaggaaatcggtcaga Quantitative real-time PCR
crp-qPCR-R tgcgtcccacggtttca Quantitative real-time PCR
glpT-footprintF-6FAM tcacttgattgcgagtcgcg Footprinting analyses
glpT-footprintR gcgaagctttgaaagcctccgtggcccgtg Footprinting analyses
uhpT-footprintF-6FAM tgcttgtttgcttatctgggg Footprinting analyses
uhpT-footprintR gcgaagcttgggttactcctgaaatgaatac Footprinting analyses
pTrcfnr-F gcgccatggtcccggaaaagcgaattatacg pTrc99Afnr construction
pTrcfnr-R gcgggatcctcaggcaacgttacgcgtatg pTrc99Afnr construction
pTrccyaA-F gcggaattctacctctatattgagactctgaaac pTrc99AcyaA construction
pTrccyaA-R gcgggatcctcacgaaaaatactgctgtaatag pTrc99AcyaA construction
pTrccrp-F gcgccatggtgcttggcaaaccgc pTrc99Acrp construction
pTrccrp-R gcgggatccttaacgagtgccgtaaacgac pTrc99Acrp construction
pTrcuhpA-F gcgccatggccaccgttgcccttatagacg pTrc99AuhpA construction
pTrcuhpA-R gcgggatcctcaccagccatcaaacatacg pTrc99AuhpA construction
Cyclic-AMP (cAMP) Assays
Intracellular cAMP levels of EHEC grown under aerobic
or anaerobic conditions were determined by using Cyclic
AMP EIA Kit (Cayman Chemical, Ann Arbor, MI). Bacteria
were grown in 20 ml of LB medium to late logarithmic
phase and harvested. The cell pellets were once washed in
phosphate buffered saline (PBS) and suspended in 0.5 ml
of EIA buffer supplied in the kit, then lysed by sonication.
The lysate was centrifuged and the amount of cAMP in the
resulting supernatant was quantified using cAMP AChE Tracer,
cAMP EIA Antiserum and Ellman’s reagent according to the
manufacturer protocol. cAMP levels in fraction of the cell
lysate were represented as pmol per cells producing 1 µg of
protein.
Overexpression and Purification of
D154AFNR and CRP
N-Terminal histidine tagged D154AFNR and CRP, His6-
D154AFNR, and His6-CRP were expressed in and purified from
E. coliRosettaTM(DE3) (Novagen/EMDBioscience, Philadelphia,
PA), respectively. We supplied 100 µM cAMP into the buffer
for purification of His6-CRP. Bacteria containing recombinant
plasmid were grown at 37◦C to an OD600 of 0.4 in LB, 0.5 mM
IPTG was then added, and culture growth was continued for
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3 h. Cells were harvested and stored at −80◦C overnight. The
cell pellet was suspended in lysis buffer (20mM Tris [pH 7.9],
500 mM NaCl and 10% glycerol) and lysed by sonication. The
lysate was centrifuged and the resulting supernatant was mixed
with Ni-NTA agarose (Qiagen, Valencia, CA) for 1 h. The agarose
was washed with 50 mM imidazol twice and then protein was
eluted with 200 mM imidazol. The protein was >95% pure as
estimated by SDS-PAGE electrophoresis and Coomassie brilliant
blue staining. Protein concentration was determined using the
Bio-Rad protein assay (Bio-Rad, Hercules, CA). The protein was
diluted into gel-shift/footprinting assay buffer (20 mM Tris [pH
7.5], 50 mM KCl, 1 mM dithiothreitol, 10% glycerol and 200 µM
cAMP) to a concentration of 4 pmol/µl, and stored at 4◦C.
Gel-Shift Assays
Gel-shift assays were performed as previously described
(Kurabayashi et al., 2015a). We used DNA probes containing
the 300 bp region upstream of the glpT and uhpT gene,
respectively. We also used a DNA fragment from Pseudomonas
aeruginosa rhlR gene as a non-specific control probe. The probe
DNA fragments (0.30 pmol) were mixed with purified CRP
and/or D154AFNR in a 10 µl reaction mixture containing gel-
shift/footprinting assay buffer described above. After incubation
for 20 min at room temperature, samples were separated by
electrophoresis on a 5% polyacrylamide Tris-glycine/EDTA
(10 mM Tris [pH 8.0], 380 mM glycine and 1mM EDTA) gel
in Tris-glycine/EDTA buffer at 4◦C. DNA bands in the gel
were stained by 10,000-fold-diluted SYBR Green I nucleic acid
stain (Lonza, Walkersville, MD), and visualized under UV light
at 300 nm.
DNase I Footprinting
DNase I footprinting was performed using a previously described
non-radiochemical capillary electrophoresis method on an ABI
PRISM genetic analyzer equipped with an ABI PRISM GeneScan
(Hirakawa et al., 2005). The 6-carboxyfluorescein (6-FAM)-
labeled (5′), 300-bp DNA fragments (starting at 300 bp upstream
of the glpT start codon and ending 1 bp upstream of the glpT
start codon for glpT probe and starting at 300 bp upstream of
the uhpT start codon and ending 1 bp upstream of the uhpT
start codon for uhpT probe, respectively) were generated by
PCR amplification with primer pairs a 6-FAM labeled forward
primer (glpT-footprintF-6FAM) and an unlabeled reverse primer
(glpT-footprintR) for glpT probe and a 6-FAM labeled forward
primer (uhpT-footprintF-6FAM) and an unlabeled reverse
primer (uhpT-footprintR) for uhpT probe. Each DNA fragment
(0.45 pmol) was mixed with purified protein (20 pmol) in a
50 µl reaction mixture containing the same buffer as above.
After incubation for 20 min at room temperature, DNase I
(0.3 units, Promega Corp., Madison, WI) was added. After
incubation for 60 s at room temperature, samples were purified
for electrophoresis on the ABI PRISM genetic analyzer apparatus.
Statistical Analysis
P-value in each assay was determined by unpaired t-test and
two-way ANOVA with the GraphPad Prism version6.00.
RESULTS
Deletion of crp or cyaA Decreases
Expression of Both glpT and uhpT in
Anaerobically-Grown EHEC While Deletion
of uhpA Only Decreases Expression of
uhpT, but Not glpT
cAMP-bound CRP (CRP-cAMP) activates expression of both
glpT and uhpT genes while UhpA activates expression of uhpT
but not glpT. The role of these activators on expression of glpT
and uhpT has been demonstrated in aerobically grown E. coli
laboratory strains (Schumacher and Bussmann, 1978; Merkel
et al., 1995). To investigate the effect of these regulators on
expression of glpT and uhpT in EHEC grown under anaerobic
conditions, we constructed crp, which encodes the regulatory
protein, cyaA, which encodes cAMP synthase and uhpA deletion
mutants in EHECO157:H7 background, andmeasured promoter
activities of glpT and uhpT via lacZ expression from the reporter
plasmids pNN-glpT-P and pNN-uhpT-P in these mutant strains
when aerobically or anaerobically grown. Previously, we found
that expression of glpT and uhpT is activated by FNR during
anaerobic culture (Kurabayashi et al., 2015a). Initially, we
showed that levels of lacZ expression from both pNN-glpT-P
and pNN-uhpT-P in the wild-type parent when grown under
anaerobic conditions were indeed higher than those when grown
under aerobic conditions, and expression levels from these two
genes under anaerobic conditions were decreased by deletion
of fnr (Figures 1A,B). We note that contribution of fnr to
uhpT expression under anaerobic conditions is partial because
significant level of lacZ expression from pNN-uhpT-P in the fnr
mutant was still observed. This observation implies that there
is yet another unknown factor that elevates expression of uhpT
during EHEC anaerobiosis.
Levels of lacZ expression from pNN-glpT-P in crp and
cyaA mutants were under detectable limit under both aerobic
and anaerobic conditions while those from pNN-uhpT-P in
these mutants was still detectable under anaerobic conditions,
however approximately 5-fold lower than the wild-type parent
(Figures 1A,B). Since CRP requires cAMP for its activity, it is
convicting that crp and cyaA mutants showed same phenotype
for glpT and uhpT expression. On the other hand, deletion of
uhpA completely abolished lacZ expression from pNN-uhpT-P,
but did not affect that from pNN-glpT-P (Figures 1A,B). These
results suggest that CRP-cAMP activates expression of both glpT
and uhpT during anaerobic cultures as aerobic cultures, and
UhpA only activates that of uhpT.
Deletion of crp, cyaA, or uhpA Leads to a
Decrease of Susceptibility to Fosfomycin
To confirm that lowered expression of glpT and uhpT in deletion
of crp, cyaA, or uhpA leads to decrease of susceptibility to
fosfomycin, we determined the MICs of fosfomycin for these
mutants with the wild-type parent, 1fnr, 1glpT, 1uhpT, and
1glpT1uhpT strains. As observed in our previous study, the
wild-type parent grown under anaerobic conditions exhibited
a lower MIC than that grown under aerobic conditions, and
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FIGURE 1 | β-Galactosidase activities of EHEC wild-type parent and its derivative mutants containing lacZ reporter plasmids grown under aerobic or
anaerobic conditions. β-Galactosidase activities from lacZ expression in these strains correspond to glpT (A) or uhpT (B) promoter activities, then were described
as Miller units. Data plotted are the means from three independent experiments; error bars indicate the standard deviations, *P < 0.01. Asterisks denote significance
for values of β-galactosidase activity in bacterial cultures under anaerobic conditions relative to those under aerobic conditions.
the fnr mutant was 4-fold lower susceptible than the wild-type
parent under anaerobic conditions, but no difference in the
MIC between these strains was seen under aerobic conditions
(Table 3). In this study, we found that deletions of crp and
cyaA decreased the susceptibility to fosfomycin up to the level
of 1glpT1uhpT strain under aerobic and anaerobic conditions
whereas the susceptibility in uhpA mutant was same as that in
uhpT mutant (Table 3). To confirm the contribution of these
regulatory genes to glpT and uhpT-dependent susceptibility of
EHEC to fosfomycin, we introduced pTrc99Afnr, pTrc99AcyaA,
pTrc99Acrp, or pTrc99AuhpA plasmid into each mutant,
and determined the MICs of fosfomycin. We observed that
MIC phenotypes on fnr, cyaA, crp, and uhpA mutants
were actually complemented by introducing exogenous gene
expression plasmids, respectively (Table 3). These observations
support the results observed in the promoter assay that
deletions of crp and cyaA decreased expression of both glpT
and uhpT, and deletion of uhpA only decreased expression
of uhpT.
Anaerobically Grown EHEC Has a Higher
Activity of CRP-cAMP
Activity of CRP-cAMP to regulate expression of target genes
is affected by levels of both cAMP and CRP in cells (Hogema
et al., 1997). These levels might be elevated during anaerobic
culture, then lead to increase of glpT and uhpT expression. To
test this hypothesis, we measured levels of intracellular cAMP
and cyaA and crp transcripts in aerobically and anaerobically
grown EHEC. We found that intracellular concentration of
cAMP in EHEC when anaerobically grown was 2-fold higher
than that when aerobically grown (Figure 2A). The data of qPCR
analyses showed higher transcripts of cyaA and crp in EHEC
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TABLE 3 | Fosfomycin MIC of EHEC O157:H7 and its derivatives.
Strain Fosfomycin MICs (µg/ml)
Aerobic Anaerobic
Parent (HH-H7-008) 4 0.5
1glpT (HH-H7-095) 32 16
1uhpT (HH-H7-097) 8 2
1glpT1uhpT (HH-H7-103) 128 64
1fnr (HH-H7-150) 4 2
1cyaA (HH-H7-153) 128 64
1crp (HH-H7-175) 128 64
1uhpA (HH-H7-174) 8 2
Parent/pTrc99A 4 0.5
1fnr/pTrc99A 4 2
1fnr/pTrc99Afnr 4 0.5
1cyaA/pTrc99A 128 64
1cyaA/pTrc99AcyaA 8 0.5
1crp/pTrc99A 128 64
1crp/pTrc99Acrp 2 0.5
1uhpA/pTrc99A 8 2
1uhpA/pTrc99AuhpA 1 0.25
grown under anaerobic conditions than aerobic conditions
(Figure 2B). To confirm that increase of CRP-cAMP activity
elevates expression of glpT and uhpT in anaerobic cultures,
we measured levels of these genes expression in the wild-
type parent grown with or without glucose under anaerobic
conditions because addition of glucose as a PTS sugar reduces
cAMP level associating with CRP-cAMP activity (Botsford and
Harman, 1992). As expected, glucose addition reduced both
expression of glpT and uhpT (Figure 2C). When the EHEC
was grown with glycerol instead of glucose, we did not observe
the reduction of glpT and uhpT expression levels because
glycerol does not affect cAMP level (Botsford and Harman, 1992;
Figure 2C). These results suggest that activity of CRP-cAMP in
EHEC when grown under anaerobic conditions is higher than
aerobic conditions, and leads to elevated expressions of glpT
and uhpT.
FNR Is Not Responsible for Increased
Activity of CRP-cAMP under Anaerobic
Conditions
FNR is a transcriptional regulator that is able to induce
expression of particular genes during anaerobic growth (Green
et al., 1996). To investigate whether FNR induces expression
of crp and cyaA genes during anaerobic growth or not,
we compared levels of these genes expression between the
wild-type parent and the fnr mutant when aerobically or
anaerobically grown by qPCR analyses. Levels of crp and cyaA
transcript in the fnr mutant when anaerobically grown were
still higher than those when aerobically grown as the wild-
type parent exhibited (Figure 3). Thus, FNR is not responsible
for the increased activity of CRP-cAMP under anaerobic
conditions.
FIGURE 2 | Activity of CRP-cAMP in the wild-type parent grown under
aerobic or anaerobic conditions. Intracellular concentration of cAMP (A)
and transcript levels of crp and cyaA together with glpT and uhpT (B) in the
wild-type parent grown under aerobic or anaerobic conditions were compared.
Intracellular concentration of cAMP is given as the amount of cAMP were
represented as pmol per cells producing one µg of protein. Transcript levels of
crp, cyaA, glpT, and uhpT were described as relative values to that of rpoD
(housekeeping gene). Data plotted are the means of two biological replicates,
error bars indicate the ranges, *P < 0.01. Asterisks denote significance for
values of intracellular cAMP or mRNA level in bacterial cultures under
anaerobic conditions relative to those under aerobic conditions. (C)
β-Galactosidase activities from lacZ expression in the wild-type parent
correspond to glpT or uhpT promoter activities were measured when grown
(Continued)
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FIGURE 2 | Continued
with or without glucose under aerobic and anaerobic conditions. Data plotted
are the means from three independent experiments; error bars indicate the
standard deviations, *P < 0.01. Asterisks denote significance for values of
β-galactosidase activity in the wild-type parent grown with glucose relative to
those in the wild-type parent grown without glucose.
FIGURE 3 | Transcript levels of crp and cyaA genes in the wild-type
parent and the fur mutant strains grown under aerobic or anaerobic
conditions. These transcript levels were described as relative values to that of
rpoD (housekeeping gene). Data plotted are the means of two biological
replicates, error bars indicate the ranges, *P < 0.01. Asterisks denote
significance for values of mRNA level in bacterial cultures under anaerobic
conditions relative to those under aerobic conditions.
CRP-cAMP and FNR Together Bind to the
Region Upstream of glpT and uhpT Genes
We previously found that FNR binds to the region upstream of
glpT and uhpT genes (Kurabayashi et al., 2015a). To determine
whether CRP-cAMP activates expression of glpT and uhpT genes
in cooperation with FNR or not, we investigated an ability of
CRP-cAMP binds to the region upstream of glpT and uhpT genes
in the presence of FNR by gel-shift assays using recombinant
proteins. To maintain the CRP protein in active form that
cAMP binds (designated CRP-cAMP), we supplied cAMP into
the buffer through the process of protein purification and gel-
shift assays. For the FNR protein, we used the mutant protein
designated D154AFNR that aspartate at amino acid residue 154
in FNR is replaced alanine because the mutant protein is still able
to form an active conformation even in the presence of oxygen
and then to bind to the target DNA in the same fashion as that
of wild-type FNR (Ziegelhoffer and Kiley, 1995). Consistent with
results of our previous study, DNA probe bands from glpT and
uhpT, but not rhlRwere shifted in the presence of the D154AFNR
protein (Figure 4). We also observed a retarded motility of the
glpT and uhpT probes when the CRP protein is present, and the
motility of these probes was further retarded in the presence of
both CRP and D154AFNR (Figure 4). These results suggest that
CRP-cAMP and FNR together bind to the region upstream of
glpT and uhpT genes, then cooperatively activate expression of
glpT and uhpT genes.
FIGURE 4 | Gel-shift assay showing binding of CRP-cAMP and
D154AFNR to the glpT and uhpT promoter. CRP and/or D154AFNR
proteins (−CRP and -D154AFNR; no protein, +CRP; 1.2 pmol of the CRP
protein, +D154AFNR; 10 pmol of the D154AFNR protein) were added to
reaction mixtures containing 0.3 pmol of DNA probe. DNA upstream of rhlR
was used as a non-binding (negative) control.
CRP-cAMP and FNR Bind to the Different
Site on the Region Upstream of glpT Gene
CRP-cAMP controls target genes in two different manners
depending on locations that it binds within region upstream
of target genes (Zhou et al., 1994). When CRP-cAMP binds
to a site which is typically distant more than 90 bp from the
transcription start point of the target gene, CRP-cAMP requires a
regulon specific activator protein for transcriptional activation. It
has been known that the uhpT gene is in this case. CRP-cAMP
binds to the inverted repeat centered at −103 position which
site is located at 30 bp region upstream of the DNA site that
UhpA binds, then UhpA is essential for uhpT gene activation
(Figure 5D; Merkel et al., 1995; Olekhnovich et al., 1999). The
data of our promoter analyses supports it because lacZ expression
from pNNuhpT in the uhpA mutant was under detectable limit
(Figure 1B). Thus, CRP-cAMP is an enhancer for uhpT gene
activation.
As the other manner for CRP-cAMP, it alone activates target
genes without any other transcriptional activators. In this case,
CRP-cAMP binds to the DNA at near position −61.5, −72.5.
−82.5, or −92.5 where CRP-cAMP and RNA polymerase bind
on the same face of the DNA helix, or CRP-cAMP partly overlays
RNA binding site, then it enables to form direct interaction
with RNA polymerase (Straney et al., 1989; Gaston et al., 1990;
Ushida and Aiba, 1990). We have shown that levels of glpT
expression in crp and cyaA mutants were under detectable limit
(Figure 1A). Therefore, we hypothesized that CRP-cAMP may
act as an essential element for glpT gene expression interacting
with RNA polymerase. To test whether this hypothesis is correct
or not, we determined the DNA site which CRP-cAMP binds
on the region upstream of glpT gene by DNase I footprinting
analyses. We found that a 25-bp region including sequence
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FIGURE 5 | Sequences of the upstream glpT and uhpT region and identification of CRP-cAMP and D154AFNR binding sites. DNase I footprinting of the
glpT promoter region. A 300-bp, 6-FAM-labeled DNA fragment was incubated in the presence or absence of CRP (20 pmol) containing cAMP (A) or D154AFNR (20
pmol) (B) and subjected to DNase I digestion. The fluorescence intensities of the DNA fragments (y axis) are plotted relative to their size in bases (x axis). One region
(outlined by the dashed line) was protected from DNase I digestion in the presence of 20 pmol protein. (C) Sequence of the upstream glpT region. The region
protected from DNase I digestion is indicated by the box. Numbers indicate relative positions to the transcript start site labeled +1. Predicted −35 box is indicated.
(D) Sequence of the upstream uhpT region. The CRP and UhpA binding site reported in previous studies (Merkel et al., 1995; Olekhnovich et al., 1999) are indicated
by the box. Numbers indicate relative positions to the transcript start site labeled +1.
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(AATGTGTGCGGCAATTCACATT) which is similar to
CRP-binding consensus motif (AA-TGTGA-[N]-TCACA-TT)
was protected from DNase I digestion by CRP-cAMP
(Figure 5A), suggesting that the CRP-cAMP binds to this
site (Gunasekera et al., 1992). The site is located at −30 to −52
position overlaying −35 box (TCACAT) that RNA polymerase
binds (Figure 5C). Thus, CRP-cAMP interacts RNA polymerase,
and it acts as an essential element for glpT gene activation. In
addition to CRP-cAMP binding site, we determined the DNA
site which FNR binds. The D154AFNR protein protected a 70-bp
region which locates at 32 bp region upstream of CRP-cAMP
binding site (Figure 5B). Within this protected region, there was
a sequence (TTGAT-TTCG-CGCAT) located at −123 to −136
position that is relatively similar to the proposed FNR-binding
motif (TTGAT-[N]4-ATCAA) (Ziegelhoffer and Kiley, 1995;
Figure 5C).
We also performed DNase I footprinting experiment to
determine FNR binding site on uhpT region upstream. However,
contrary to the result of gel-shift assays, we did not observe
specific binding of the D154AFNR protein on the DNA probe
from uhpT region upstream in footprinting experiment (data not
shown).
DISCUSSION
Susceptibility to fosfomycin is affected by expression of GlpT
and UhpT transporters. CRP-cAMP is an activator of both
glpT and uhpT genes while UhpA activates only the uhpT
gene (Schumacher and Bussmann, 1978; Merkel et al., 1995).
Among clinically isolated E. coli strains, mutations in uhpA and
cyaA genes confer resistance to fosfomycin (Nilsson et al., 2003;
Takahata et al., 2010). Fosfomycin is unable to be sufficiently
transported into these mutant cells due to very low levels of
glpT and uhpT expression. On the other hand, a mutant that
overproduces MurA, the target of fosfomycin was isolated, and
this strain is resistant to fosfomycin, however the mutation site
remains uncharacterized (Horii et al., 1999).
Levels of glpT and uhpT are elevated when EHEC are
grown under anaerobic conditions, which leads to increase
of susceptibility to fosfomycin followed by increased uptake
of this drug. We previously showed that levels of glpT and
uhpT expression during anaerobic growth are elevated by FNR,
a transcriptional regulator that is activated under anaerobic
conditions (Kurabayashi et al., 2015a). In this study, we found
that levels of both CRP and cAMP in EHEC were increased, and
resulted in elevation of GlpT and UhpT expression (Figures 1,
2). Thus, increased susceptibility to fosfomycin under anaerobic
conditions is due to elevation of GlpT and UhpT expression
followed by activation of FNR and increment of CRP-cAMP
amount.
According to the Clinical and Laboratory Standards Institute
(CLSI), the in vivo antibacterial activity of fosfomycin against E.
coli species is relatively lower than that of other commonly used
antibiotics, such as β-lactams and fluoroquinolones (Clinical
Laboratory Standards Institute, 2011). The antibacterial activity
was evaluated in aerobic cultures. However, E. coli species
including EHEC are usually in oxygen-limited situations during
infections, for instance, available oxygen is depleted at enteric
sites where they reside or cause infection. In many cases, E. coli
grows with other members in a microbial complex as biofilm.
Therefore, we suggest that in vitro test may underestimate the
in vivo potency of fosfomycin utility.
The manner of gene activation by CRP-cAMP with FNR is
different between glpT and uhpT. We suggest that CRP-cAMP
probably interacts with the RNA polymerase subunit on glpT
gene promoter, then acts as an essential element for glpT gene
activation under both aerobic and anaerobic conditions. Results
obtained in gel-shift assays, footprinting analyses and promoter
assays support this idea because purified CRP-cAMP protein
binds on RNA binding site and crp and cyaA mutants showed
very low activity of glpT promoter even when anaerobically
grown (Figures 1A, 4, 5A,C). Then, FNR further enhances the
glpT transcription activated by CRP-cAMP and RNA polymerase
(Figures 4, 5B,C). On the other hand, CRP-cAMP is not essential
for uhpT transcription because crp and cyaA mutants are still
able to express the uhpT gene at moderate level. Transcription
of uhpT absolutely requires UhpA (Figure 1B). According to
other studies, CRP-cAMP binds to a region that is relatively
remote from the RNA polymerase binding site on the uhpT
gene promoter, and then it stabilizes the complex of RNA
polymerase, the promoter DNA, and UhpA (Merkel et al., 1995;
Olekhnovich et al., 1999; Figure 5D). Thus, CRP-cAMP aids
UhpA to activate the expression of uhpT. Results of our promoter
assays agree with it. We do not still know how FNR involves
in activation of uhpT by UhpA and CRP-cAMP. Deletion of
fnr moderately decreases the expression of uhpT, however we
did not observe a specific binding to region upstream of uhpT
gene in footprinting experiment (Figure 1B and data not shown).
Gel-shift assays showed that purified FNR protein bound the
DNA probe from uhpT region upstream of uhpT gene with
much lower affinity than that of glpT although no similar
conserved consensus sequence that FNR probably binds on the
region upstream was seen (Figure 4; Kurabayashi et al., 2015a).
Therefore, unlikely UhpA and CRP-cAMP, the activation of
uhpT gene promoter by FNR may be indirect in physiological
situations. We also note that FNR does not increase activity of
CRP-cAMP because there was no difference in levels of crp and
cyaA transcription between the wild-type parent and fnr mutant
(Figure 3). Further studies will be necessary to get insights into
the molecular mechanism of uhpT gene regulation associating
with FNR.
Why is expression of GlpT and UhpT elevated under
anaerobic conditions? The native substrates of GlpT and UhpT
transporters are glycerol-3-phosphate and glucose-6-phosphate,
respectively (Kadner and Winkler, 1973; Argast et al., 1978).
E. coli strains including EHEC use these compounds as carbon
sources for growth (Kurabayashi et al., 2014). In addition,
glycerol-3-phosphate can be utilized as an electron donor for
anaerobic respiration (Varga and Weiner, 1995; Unden and
Bongaerts, 1997). Therefore, elevated expression of GlpT and
UhpT may reduce metabolic cost of bacteria during anaerobic
growth. However, as a tradeoff of this benefit for bacteria,
the susceptibility to fosfomycin is increased. As experimental
observations to support this literature, constitutive reduction of
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GlpT and UhpT expression in mutant EHEC strains lose the
biological fitness, and the strains is outcompeted by the wild-
type parent strain that express GlpT and UhpT in normal level
(Kurabayashi et al., 2014).
As far as we compared sequences among EHEC O157 and
some other E. coli members including MG1655, laboratory-K12
strain and CFT073, uropathogenic E. coli (UPEC), sequences
of glpT, uhpT and their regulatory genes such as fnr, uhpA,
cyaA, and crp are highly conserved (>95% identity). Therefore,
we believe that regulatory mechanism of glpT and uhpT genes
associating with FNR, UhpA, CyaA, and CRP may be conserved
in E. coli species although it is speculative. In addition to E. coli,
some of other species are also more susceptible to fosfomycin
under anaerobic conditions than aerobic conditions (Inouye
et al., 1989). Several enterobacteria members genetically close to
E. coli, such as Salmonella and Shigella have glpT, uhpT and their
regulatory genes sharing >88% sequence identity with those in
E. coli. However, typical non-enterobacterial MDR pathogens,
such as P. aeruginosa and S. aureus lack some regulatory genes
that probably control expression of glpT and uhpT. In addition,
P. aeruginosa has no uhpT and fnr genes in chromosome
(Castaneda-Garcia et al., 2009). Therefore, we presume that
the regulatory system of glpT and uhpT gene expression to
determine susceptibility to fosfomycin observed in EHEC could
be conserved in only E. coli and genetically close members while
P. aeruginosa and S. aureus could become highly susceptible
to this drug under anaerobic conditions in any other unknown
mechanism.
In this study, we found targets to elevate expression of glpT
and uhpT transporters under anaerobic conditions, and provided
insights into the molecular mechanism of increased susceptibility
to fosfomycin. It will aid us to not only more precisely estimate
utility and potency of fosfomycin, but also offer a method
to promote fosfomycin therapy such as modeling drugs that
expression of GlpT andUhpT transporters can bemore activated.
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